Moneycontrol PRO
Loans
Loans
HomeNewsBusinessMoneycontrol ResearchWhat does Trump’s MFN clause mean for the Indian pharma landscape?

What does Trump’s MFN clause mean for the Indian pharma landscape?

The new regulation appears to be less disruptive for the Indian generics; may impact those having exposure to speciality/patented portfolios

May 13, 2025 / 09:40 IST
Most Favoured Nation clause is less bothersome than feared
  • PRO Panorama

    Moneycontrol Pro Panorama | Copper crunch

    Dec 8, 2025 / 03:40 PM IST

    In Moneycontrol's Pro Panorama December 8 edition: Indian consumer optimism decoded, IndiGo debacle fallout explained, 2025 gold r...

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | Samvat 2082: The Will to Rise

    Oct 18, 2025 / 10:00 AM IST

    After a turbulent Samvat 2081, the markets step into the new year not with fireworks but with quiet resolve and the will to rise

    Read Now
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts

Disclosure & Disclaimer

This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More